In vivo myocardial tissue kinetics of Gd(ABE-DTTA), a tissue-persistent contrast agent

Magnetic Resonance in Medicine

Volumn 58, Issue 1, 2007, Pages 55-64

  Surányi, Pál ^a,e   Kiss, Pál ^a,e   Ruzsics, Balazs ^a   Brott, Brigitta C ^b   Simor, Tamás ^a,e   Elgavish, Ada ^c,e   Baker, Robert A ^d   Saab Ismail, Nada H ^e   Elgavish, Gabriel A ^a,b,e  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b University of Alabama at Birmingham and Birmingham Veterans Affairs Medical Center   (United States)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^d UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^e Elgavish Paramagnetics Inc   (United States)

Author keywords

Contrast agent kinetics; Magnetic resonance imaging; Myocardial infarction; R1 mapping

Indexed keywords

BLOOD; CARDIOLOGY; CURVE FITTING; KINETICS; MAGNETIC RESONANCE IMAGING;

CONTRAST AGENT; GRADIENT ECHO; INTRAVASCULAR; INVERSION RECOVERY; MYOCARDIAL INFARCTION; MYOCARDIAL TISSUE; PROGRESSIVE ACCUMULATION; SIGNAL INTENSITIES;

TISSUE;

CONTRAST MEDIUM; GADOLINIUM (ACUTE BACTERIAL ENDOCARDITIS DIETHYLENETRIAMINETRIACETIC ACID); GADOLINIUM PENTETATE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BALLOON CATHETER; DOG; DRUG ACCUMULATION; DRUG CLEARANCE; HEART INFARCTION; HEART MUSCLE REPERFUSION; IMAGE PROCESSING; IN VIVO STUDY; MALE; MEASUREMENT; NONHUMAN;

EID: 34547767721     PISSN: 07403194     EISSN: 15222594     Source Type: Journal    
DOI: 10.1002/mrm.21249     Document Type: Article

References (45)

1. McNamara MT, Tscholakoff D, Revel D, Soulen R, Schechtmann N, Botvinick E, Higgins CB. Differentiation of reversible and irreversible myocardial injury by MR imaging with and without gadolinium-DTPA. Radiology 1986;158:765-769.
2. Tscholakoff D, Higgins CB, Sechtem U, McNamara MT. Occlusive and reperfused myocardial infarcts: effect of Gd-DTPA on ECG-gated MR imaging. Radiology 1986;160:515-519.
3. Rehr RB, Peshock RM, Malloy CR, Keller AM, Parkey RW, Buja LM, Nunnally RL, Willerson IT. Improved in vivo magnetic resonance imaging of acute myocardial infarction after intravenous paramagnetic contrast agent administration. Am J Cardiol 1986;57:864-868.
4. Peshock RM, Malloy CR, Buja LM, Nunnally RL, Parkey RW, Willerson JT. Magnetic resonance imaging of acute myocardial infarction: gadolinium diethylenetriamine pentaacetic acid as a marker of reperfusion. Circulation 1986;74:1434-1440.
5. Saeed M, Lund G, Wendland MF, Bremerich J, Weinmann H, Higgins CB. Magnetic resonance characterization of the peri-infarction zone of reperfused myocardial infarction with necrosis-specific and extracellular nonspecific contrast media. Circulation 2001;103:871-876.
6. Oshinski JN, Yang Z, Jones JR, Mata JF, French BA. Imaging time after Gd-DTPA injection is critical in using delayed enhancement to determine infarct size accurately with magnetic resonance imaging. Circulation 2001;104:2838-2842.
7. Choi SH, Lee SS, Choi SI, Kim ST, Lim KH, Lim CH, Weinmann H-J, Lim T-H. Occlusive myocardial infarction: investigation of Bis-gadolinium mesoporphyrins-enhanced T1-weighted MR imaging in a cat model. Radiology 2001;220:436-440.
8. Watzinger N, Lund GK, Higgins CB, Wendland MF, Weinmann HJ, Saeed M. The potential of contrast-enhanced magnetic resonance imaging for predicting left ventricular remodeling. J Magn Reson Imaging 2002;16:633-640.
9. Van Rossum AC, Visser FC, Van Eenige MJ, Sprenger M, Valk J, Verheugt FW, Roos JP. Value of gadolinium-diethylene-triamine pentaacetic acid dynamics in magnetic resonance imaging of acute myocardial infarction with occluded and reperfused coronary arteries after thrombolysis. Am J Cardiol 1990;65:845-851.
10. Gerber BL, Rochitte CE, Bluemke DA, Melin JA, Crosille P, Becker LC, Lima JAC. Relation between Gd-DTPA contrast enhancement and regional inotropic response in the periphery and center of myocardial infarction. Circulation 2001;104:998-1004.
11. Gerber BL, Garot J, Bluemke DA, Wu KC, Lima JA. Accuracy of contrast-enhanced magnetic resonance imaging in predicting improvement of regional myocardial function in patients after acute myocardial infarction. Circulation 2002;106:1083-1089.
12. Judd RM, Lugo-Olivieri CH, Arai M, Kondo T, Croisille P, Lima JA, Mohan V, Becker LC, Zerhouni EA. Physiological basis of myocardial contrast enhancement in fast magnetic resonance images of 2-day-old reperfused canine infarcts. Circulation 1995;92:1902-1910.
13. Kim RJ, Fieno DS, Parrish TB, Harris K, Chen EL, Simonetti O, Bundy J, Finn JP, Klocke FJ, Judd RM. Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. Circulation 1999;100:1992-2002.
14. Lima JA, Judd RM, Bazille A, Schulman SP, Atalar E, Zerhouni EA. Regional heterogeneity of human myocardial infarcts demonstrated by contrast-enhanced MRI: potential mechanisms. Circulation 1995;92:1117-1125.
15. Kim RJ, Chen EL, Lima JA, Judd RM. Myocardial Gd-DTPA kinetics determine MRI contrast enhancement and reflect the extent and severity of myocardial injury after acute reperfused infarction. Circulation 1996;94:3318-3326.
16. Simor T, Chu WJ, Johnson L, Safranko A, Doyle M, Pohost GM, Elgavish GA. In vivo MRI visualization of acute myocardial ischemia and reperfusion in ferrets by the persistent action of the contrast agent Gd (BME-DTTA). Circulation 1995;92:3549-3559.
17. Saab-Ismail NH, Simor T, Gaszner B, Lorand T, Szollosy M, Elgavish GA. Synthesis and in vivo evaluation of new contrast agents for cardiac MRI. J Med Chem 1999;42:2852-2861.
18. Kim SK, Pohost GM, Elgavish GA. Gadolinium complexes of [(myristoyloxy) propyl)diethylenetriaminetetraacetate: new lipophilic, fatty acyl conjugated NMR contrast agents. Bioconj Chem 1992;3:20-26.
19. Kim SK, Pohost GM, Elgavish GA. Fatty-acyl iminopolycarboxylates: lipophilic bifunctional contrast agents for NMR imaging. Magn Reson Med 1991;22:57-67.
20. Chu WJ, Elgavish GA. Gadolinium and dysprosium chelates of DTPA-amide-dextran: synthesis, 1H NMR relaxivity, and induced 23Na NMR shift. NMR Biomed 1995;8:159-163.
21. Chu WJ, Simor T, Elgavish GA. In vivo characterization of Gd(BME-DTTA), a myocardial MRI contrast agent: tissue distribution of its MRI intensity enhancement, and its effect on heart function. NMR Biomed 1997;10:87-92.
22. Surányi P, Kiss P, Brott BC, Simor T, Elgavish A, Elgavish GA. Repeated, pixel-by-pixel T1-mapping in canine myocardial infarction, using an infarct-avid, persistent contrast agent, Gd(ABE-DTTA). In: Proceedings of the 12th Annual Meeting of ISMRM, Kyoto, Japan, 2004 (Abstract 172).
23. Surányi P, Kiss P, Brott BC, Simor T, Elgavish A, Elgavish GA. Determining tissue kinetics of Gd(ABE-DTTA), an infarct-avid, persistent contrast-agent in canine myocardial infarction. In: Proceedings of the 12th Annual Meeting of ISMRM, Kyoto, Japan, 2004 (Abstract 1836).
24. Simor T, Gaszner B, Oshinski J, Waldrop S, Pettigrew R, Horvath I, Hild G, Elgavish G. Gd(ABE-DTTA)-enhanced cardiac MRI for the diagnosis of ischemic events in the heart. J Magn Reson Imaging 2005;21:536-545.
25. Kiss P, Suranyi P, Simor T, Saab-Ismail NH, Elgavish A, Hejjel L, Elgavish GA. In vivo T1 mapping of canine hearts using Gd(ABE-DTTA) in an ischemia-reperfusion model. In: Proceedings of the 11th Annual Meeting of ISMRM, Toronto, Canada, 2003 (Abstract 649).
26. Kiss P, Surányi P, Simor T, Saab-Ismail NH, Elgavish A, Hejjel L, Elgavish GA. In vivo R1-enhancement mapping of canine myocardium using ceMRI with Gd(ABE-DTTA) in an acute ischemia-reperfusion model. J Magn Reson Imaging 2006;24:571-579.
27. Surányi P, Kiss P, Brott BC, Simor T, Elgavish A, Ruzsics B, Saab-Ismail NH, Elgavish GA. Percent infarct mapping: an R1-map-based CE-MRI method for determining myocardial viability distribution. Magn Reson Med 2006;56:535-545.
28. Ruzsics B, Surányi P, Kiss P, Brott B, Elgavish A, Saab-Ismail N, Simor T, Elgavish G. Gd(ABE-DTTA), a novel contrast agent, at the MRI-effective dose shows absence of deleterious physiological effects in dogs. Pharmacology 2006;77:188-194.
29. Tweedle MF, Wedeking P, Telser J, Sotak CH, Chang CA, Kumar K, Wan X, Eaton SM. Dependence of MR signal intensity on Gd tissue concentration over a broad dose range. Magn Reson Med 1991;22:191-194.
30. Kaldoudi E, Williams SCR. Relaxation time measurements in NMR imaging. Part I: Longitudinal relaxation time. Concepts Magn Reson 1993;5:217-242.
31. Kiss P, Simor T, Lenard L, Hejjel L, Suranyi P, Saab-Ismail NH, Elgavish GA. Relaxivity of Gd.(ABE-DTTA) increases with magnetic field strength up to 5T. A contrast agent for high field imaging. In: Proceedings of the 10th Annual Meeting of ISMRM, Honolulu, HI, USA, 2002 (Abstract 2591).
32. Stanisz G, Henkelman R. Gd-DTPA relaxivity depends on macromolecular content. Magn Reson Med 2000;44:665-667.
33. Messroghli DR, Niendorf T, Schulz-Menger J, Dietz R, Friedrich MG. T1 mapping in patients with acute myocardial infarction. J Cardiovasc Magn Reson 2003;5:353-359.
34. 13C spin-lattice relaxation measurements by inversion-recovery. J Magn Reson 1975;18:199-204.
35. Nekolla S, Gneiting T, Syha J, Deichmann R, Haase A. T1 maps by k-space reduced snapshot-FLASH MRI. J Comput Assist Tomogr 1992;16:327-332.
36. Fallon J. Postmortem histochemical techniques. In: GS W, editor. Myocardial infarction: measurement and intervention. Boston: Martinus Nijhoff Publishers; 1982. p 373-384.
37. Lauffer R, Parmelee D, Dunham S, Ouellet H, Dolan R, Witte S, McMurry T, Walovitch R. MS-325: albumin-targeted contrast agent for MR angiography. Radiology 1998;207:529-538.
38. Adzamli K, Yablonskiy D, Chicoine M, Won E, Galen K, Zahner M, Woolsey T, Ackerman J. Albumin-binding MR blood pool agents as MRI contrast agents in an intracranial mouse glioma model. Magn Reson Med 2003;49:586-590.
39. He X, Carter D. Atomic structure and chemistry of human serum albumin. Nature 1992;358:209-215.
40. Lindner JR, Skyba DM, Goodman NC, Jayaweera AR, Kaul S. Changes in myocardial blood volume with graded coronary stenosis. Am J Physiol Heart Circ Physiol 1997;272:H567-575.
41. Wu X, Ewert D, Liu Y, Ritman E. In vivo relation of intramyocardial blood volume to myocardial perfusion. Evidence supporting microvascular site for autoregulation. Circulation 1992;85:730-737.
42. Morgenstern C, Holjes U, Arnold G, Lochner W. The influence of coronary pressure and coronary flow on intracoronary blood volume and geometry of the left ventricle. Pflugers Arch 1973;340:101-111.
43. Weiss H, Winbury M. Nitroglycerin and chromonar on small-vessel blood content of the ventricular walls. Am J Physiol 1974;226:838-843.
44. Vexler V, Clement O, Schmitt-Willich H, Brasch R. Effect of varying the molecular weight of the MR contrast agent Gd-DTPA-polylysine on blood pharmacokinetics and enhancement patterns. J Magn Reson Imaging 1994;4:381-388.
45. Ni Y, Pislaru C, Bosmans H, Pislaru S, Miao Y, Bogaert J, Dymarkowski S, Yu J, Semmler W, Van de Werf F, Baert A, Marchal G. Intracoronary delivery of Gd-DTPA and Gadophrin-2 for determination of myocardial viability with MR imaging. Eur Radiol 2001;11:876-883.